Acrivon Therapeutics, Inc. (ACRV) Financials

$2.15

$0.08 (3.86%)

As on 02-Sep-2026 16:00EDT

Market cap

$88 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

1.1

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	-0.23	1.36	1.01	0.54	1.10	0.83
Gross Profit	0.23	-1.36	-1.01	-0.54	-1.10	-0.83
Operating Expenses	78.90	82.76	88.19	66.70	32.66	16.18
Operating Profit (EBIT)	-78.37	-84.11	-89.20	-67.24	-32.66	-16.18
Other Income	--	--	--	--	1.49	--
Profit before Tax	-74.23	-77.91	-80.56	-60.39	-31.17	-16.24
Provision for Tax	--	--	--	0.00	-1.49	-0.20
Profit after Tax (Net Income)	-74.23	-77.91	-80.56	-60.39	-29.68	-16.24
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-31.17	-16.24

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	86.67	112.52	176.79	121.20	170.48	-23.81
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.98	1.54	2.59	3.77	4.24	127.48
Current Liabilities	11.45	15.66	17.21	13.30	6.52	2.91
Total Liabilities	110.54	129.72	196.59	138.27	181.23	106.59

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	7.60	9.27	14.96	8.57	49.13	6.18
Current Assets	91.49	120.45	181.63	129.69	132.10	100.41
Total Assets	190.59	129.72	196.59	138.27	181.23	106.59
Total Debt*	2.12	2.71	3.65	4.64	4.96	5.63
Net Current Assets	--	104.78	164.42	116.39	125.58	97.49

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-63.67	-65.67	-42.64	-30.12	-13.98
Cash Flow from Investing Activities	--	66.10	-51.77	50.72	-141.68	-0.24
Cash from Financing Activities	--	-0.75	121.03	-1.55	101.71	112.22
Net Cash Inflow / Outflow	--	--	--	--	-70.08	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-1.89	-2.02	-2.11	-2.70	-1.42	-1.26
Cash EPS ($)	--	-1.99	-2.08	-2.68	-1.40	-1.26
Adjusted Book Value ($)	--	2.92	4.62	5.43	8.16	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.65	-1.72	-1.91	-1.44	-1.08
Free Cash Flow per Share ($)	--	-1.70	-1.79	-1.97	-1.55	-1.10

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-52.70	-52.60	-40.09	-37.74	122.42
ROE (%)	-74.53	-53.86	-54.07	-41.41	-40.47	100.82
ROA (%)	-40.94	-47.75	-48.11	-37.80	-20.62	-29.87
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	-1,991.74	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	6.43	3.29	-33.40	-84.92	-101.05	-206.13
Net Profit Growth (%)	13.65	3.29	-33.40	-103.48	-82.71	-206.13
EPS Growth (%)	15.96	0.04	0.22	-0.90	-0.13	--
Book Value Growth (%)	-44.31	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-1.19	-2.86	-1.82	-8.11	--
Price / Book Value	1.07	0.82	1.30	0.91	1.41	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.43	0.30	-0.68	0.22	-3.65	--
Close Price ($)	1.78	2.41	6.02	4.92	11.52	--
High Price ($)	3.56	8.00	11.90	25.47	20.70	--
Low Price ($)	1.15	1.05	3.19	3.41	10.90	--
Market Cap ($ Cr)	88.28	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.02	0.02	0.04	0.03	-0.24
Short term debt to equity ratio	0.01	0.01	0.01	0.01	0.00	-0.03
Current Ratio	7.99	7.69	10.55	9.75	20.27	34.46
Quick Ratio	7.99	--	--	--	--	--
Interest Coverage	--	--	--	--	-21.92	-275.31

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	408.75	1,054.00	2,027.96	311.55	241.45
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.